Rare
lephants
Screener
Toggle theme
Acurx Pharmaceuticals, Inc.
ACXP
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Assets & Liabilities
Equity & Debt
Asset & Liabilities Breakdown
Balance Sheet
›
Assets & Liabilities
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Assets & Liabilities
Chart
Table
Total Liabilities
Total Assets
Cash on Hand
Fiscal Year
Total Liabilities
Total Assets
Cash on Hand
FY2025
$2.4M
$7.7M
$7.6M
Download CSV
